Artificial Intelligence

A novel drug that glues cancer proteins to the cellular trash system has entered human trials, offering new hope for rare diseases like Ewing sarcoma.

Zebra Technologies launches new AI-powered mobile computers and a suite of software solutions, aiming to redefine retail efficiency and empower associates.

Biotech firm Bright Minds Biosciences closes a massive $175M deal, fueling its race to develop novel drugs for epilepsy and rare neurological conditions.

Promising Phase 2 data shows a new DNA immunotherapy for advanced melanoma, delivered via a needle-free jet injector, significantly improves patient outcomes.

As AI creates a hardware deficit, FiberMall's mass shipment of 400G/800G optical transceivers aims to solve a critical data bottleneck for global AI.

A new alliance aims to advance KFRX06, a unique Parkinson's therapy that goes beyond a single target to potentially offer a more comprehensive treatment.

Pomeroy launches an immersive Client Experience Center in Manhattan, using hands-on tech to transform sales into a collaborative innovation process.

A new $50M venture fund from Penn, BioNTech, and OUP aims to turn the university's breakthrough research into life-saving therapies faster than ever.

Meta's historic nuclear energy purchase signals a major shift in Big Tech's strategy to meet soaring AI power demands and reshape the US energy grid.

Maria Montenegro, an AI and M&A expert, takes the helm of the CP & ESG unit, signaling a major push into tech-driven corporate compliance and performance.

With a new board appointment and $19M in funding, Enhanced Genomics is leveraging its 3D genomics platform to build its own pipeline of precision therapies.

With a new Deputy CEO and CFO, newcleo accelerates its mission to power the world with recycled nuclear waste, reshaping the global energy landscape.

Automated Industrial Robotics Inc. acquires Ireland's KAON Automation, a strategic move to dominate the high-stakes medical and life sciences market.

Office leasing rose 5% in 2025, but a closer look reveals a fractured recovery, with tech hubs booming while others lag and companies shrink their footprints.

With a major Series B led by IDG Capital, PhotonPay is accelerating its mission to re-architect global payments with a stablecoin-native infrastructure.

At CES 2026, Jinxin Technology unveiled NAMI INSIGHT One, AI-powered learning glasses aiming to revolutionize education. But can it overcome the hurdles?

Akari Therapeutics is advancing a new class of cancer drugs. Its unique PH1 payload kills tumors and activates the immune system, setting up a pivotal 2026.

With a new $1.6B valuation led by T. Rowe Price, Hadrian is scaling its AI-powered factories to spearhead America's industrial and defense resurgence.

Amid rising regulatory pressure, dxFeed's flawless performance in a critical industry-wide disaster recovery test sets a new benchmark for data reliability.

A new collaboration between the Global Alzheimer's Platform and Alamar Biosciences aims to revolutionize diagnosis with ultra-sensitive blood tests for all.